CLASS I ONGOING Device recall · Reported 21 Oct 2026 · FDA Enforcement Report

HemoslL AcuStar HIT-lgG(PF-4) recalled by Instrumentation Laboratory

Instrumentation Laboratory is recalling HemoslL AcuStar HIT-lgG(PF-4), distributed nationwide in the US. The recall was initiated on 3 Sep 2026 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesPart Number: 0009800127. UDI-DI: 08426951126545. Lot Number (Expiration Date): B40005 (01/16/2027), B38062 (11/01/2026).
Quantity recalled434 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0001-2027
FDA event ID
99843
Recalling firm
Instrumentation Laboratory, Bedford, MA
Classification
Class I
Status
Ongoing
Recall initiated
3 Sep 2026
FDA classified
9 Oct 2026
Reported
21 Oct 2026
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

3 Sep 2026Recall initiated by company
9 Oct 2026Classified by FDA+36 days
21 Oct 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for invalid calibration curve or negative mean bias of up to 47% with patient samples.

Product as listed by the FDA

HemoslL AcuStar HIT-lgG(PF-4). Part Number: 0009800127. in vitro diagnostic

Where it was distributed

Worldwide - US Nationwide distribution in the states of AR, AZ, CA, CT, FL, GA, MA, MD, NJ, NY, PA, RI, TN, WA, WV and the countries of Austria, Belgium, Switzerland, Costa Rica, Czech Republic, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, India, Italy, Jordan, Japan, South Korea, Luxembourg, Latvia, Netherlands, Saudi Arabia, Sweden, Singapore.

Nationwide ArkansasArizonaCaliforniaConnecticutFloridaGeorgiaMassachusettsMarylandNew JerseyNew YorkPennsylvaniaRhode IslandTennesseeWashingtonWest Virginia

Questions about this recall

Why was it recalled?

Potential for invalid calibration curve or negative mean bias of up to 47% with patient samples.

Which lots are affected?

Part Number: 0009800127. UDI-DI: 08426951126545. Lot Number (Expiration Date): B40005 (01/16/2027), B38062 (11/01/2026).

Where was it sold?

Worldwide - US Nationwide distribution in the states of AR, AZ, CA, CT, FL, GA, MA, MD, NJ, NY, PA, RI, TN, WA, WV and the countries of Austria, Belgium, Switzerland, Costa Rica, Czech Republic, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, India, Italy, Jordan, Japan, South Korea, Luxembourg, Latvia, Netherlands, Saudi Arabia, Sweden, Singapore.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 27 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 99843

This product is part of a recall event; the main page for the event is HemoslL AcuStar HIT-lgG(PF-4) recalled by Instrumentation Laboratory.

ReportedClassRecallCompanyReasonWhere
CLASS IHemoslL AcuStar HIT-lgG(PF-4) recalled by Instrumentation LaboratoryInstrumentation LaboratoryOtherNationwide

More recalls from Instrumentation Laboratory

All 79

Other Test Kits & Diagnostics recalls

All 2,668